Is Procter & Gamble Worth Its Premium Price?


The company’s current much-touted pricing power is evanescent and will diminish as competition increases and the staples sector continues to experience profound change



Procter & Gamble Co. (NYSE:PG) posted good results for its latest quarter, exceeding analyst expectations for some measures.

Earnings per share were $1.21, beating the consensus of $1.21. At $17.44 billion, net sales remained unchanged from the prior year. The company’s sales were not uniform across all its segments. While the beauty products logged an 8% increase in organic sales, other areas, such as diapers and its Gillette shaving products division, continue to be flat. The steady erosion in Gillette’s share of the razor market has been pronounced. In many ways, it could be construed as a bellwether for the company in particular and the entire consumer staples sector in general.




After several quarters of anemic growth, investors were understandably ebullient that the company had first and second back-to-back quarters of 4% organic sales growth. However, it is paramount to note that the price increases have been announced but have not yet been fully implemented. How consumers will react remains to be seen, prompting the question: Should the stock command a premium multiple?




In case you interested of stock analysis of other bloggers, click on link below:




Analysis Collection


Comments